Ile-Ala-Leu-Ile-Leu-Glu-Pro-Ile-Cys-Cys-Gln-Glu-Arg-Ala-Ala-(Discrete-Polyethylene Glycol)24

2 trials Orphan designation

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

2 Countries

Phase II

Phase II: 2

Oversight events:

1 temporary halt 2 unexpected events across 1 trial

View oversight register →

Indications tested

Acute graft versus host disease 2

Sponsors using this IMP

Realta Life Sciences Inc. 2

All trials

2 total

Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacok… Not authorised

2024-510582-42-00 Phase II 2 countries Realta Life Sciences Inc.
Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacok… Ended

2024-510582-42-02 Phase II 2 countries Realta Life Sciences Inc.

Showing 1–2 of 2 trials

← All drugs A–Z